BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,036 | -7.9% | 33,515 | +22.3% | 0.00% | – |
| Q2 2023 | $875,106 | +12.5% | 27,407 | +7.9% | 0.00% | – |
| Q1 2023 | $778,054 | -22.2% | 25,410 | -0.7% | 0.00% | -100.0% |
| Q4 2022 | $1,000,434 | -16.8% | 25,580 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $1,202,291 | +20.8% | 25,237 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $995,041 | -18.2% | 25,705 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $1,216,708 | -40.7% | 21,234 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $2,052,000 | -6.8% | 25,750 | +1.8% | 0.00% | -50.0% |
| Q3 2021 | $2,201,000 | -35.0% | 25,297 | -3.8% | 0.00% | -33.3% |
| Q2 2021 | $3,384,000 | +90.3% | 26,290 | +18.3% | 0.00% | +50.0% |
| Q1 2021 | $1,778,000 | -7.7% | 22,220 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $1,927,000 | +295.7% | 23,609 | +19.3% | 0.00% | +100.0% |
| Q3 2020 | $487,000 | – | 19,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |